A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Conditions

Healthy Adult Male Subjects

Interventions

DRUG

[14C]ONO-4053

Single dose \[14C\]ONO-4053

Trial Locations (1)

Nottingham Clinical site, Nottingham